AMICAR (Clover Pharmaceuticals Corp.)
Welcome to the PulseAid listing for the AMICAR drug offered from Clover Pharmaceuticals Corp.. This Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Clover Pharmaceuticals Corp. |
NON-PROPRIETARY NAME: | Aminocaproic Acid |
SUBSTANCE NAME: | AMINOCAPROIC ACID |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2015-06-01 |
END MARKETING DATE: | 0000-00-00 |
AMICAR HUMAN PRESCRIPTION DRUG Details:
Item Description | AMICAR from Clover Pharmaceuticals Corp. |
LABELER NAME: | Clover Pharmaceuticals Corp. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.25(g/mL) |
START MARKETING DATE: | 2015-06-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 49411-052_bba3bfb1-b56e-4370-8b68-25f18db3fc02 |
PRODUCT NDC: | 49411-052 |
APPLICATION NUMBER: | NDA015230 |
Other AMINOCAPROIC ACID Pharmaceutical Manufacturers / Labelers: